Joon Lee
Stock Analyst at Truist Securities
(2.34)
# 1076
Out of 5,218 analysts
119
Total ratings
48.10%
Success rate
35.68%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
WAVE Life Sciences | Maintains: Strong Buy | 17 36 | 13.43 | 168.06% | 3 | Nov 12, 2024 | |
Catalyst Pharmaceuti... | Maintains: Strong Buy | 30 36 | 21.36 | 68.54% | 7 | Nov 11, 2024 | |
Editas Medicine | Maintains: Buy | 12 8 | 1.44 | 455.56% | 7 | Nov 5, 2024 | |
argenx | Maintains: Strong Buy | 540 660 | 606.64 | 8.8% | 11 | Oct 31, 2024 | |
Sage Therapeutics | Maintains: Hold | 13 8 | 5.34 | 49.81% | 11 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 12 17 | 8.37 | 103.11% | 7 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 60 60 | n/a | n/a | 2 | Oct 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 38 44 | 41.41 | 6.25% | 5 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 65 76 | 55.4 | 37.18% | 7 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 118 90 | 66.03 | 36.3% | 2 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 60 40 | 5.38 | 643.49% | 6 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 120 100 | 43.75 | 128.57% | 4 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Strong Buy | 508 550 | 463.5 | 18.66% | 1 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 120 120 | 12.89 | 830.95% | 3 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 10 10 | 0.26 | 3746.15% | 7 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 120 120 | 46.98 | 155.43% | 7 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 150 150 | 69.98 | 114.35% | 3 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 150 | 90.01 | 66.65% | 2 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 65 | 19.42 | 234.71% | 5 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 200 | 123 | 62.6% | 2 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 6 5 | 2.06 | 142.72% | 7 | Sep 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 18 | 6.25 | 188% | 1 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 22 25 | n/a | n/a | 2 | Sep 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 280 | 3.45 | 8015.94% | 1 | Oct 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 45 50 | n/a | n/a | 1 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 360 | 0.37 | 97197.3% | 2 | Mar 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 27 34 | 15.6 | 117.95% | 1 | Mar 16, 2021 |